These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32240273)

  • 1. New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia.
    Tarancón R; Domínguez-Andrés J; Uranga S; Ferreira AV; Groh LA; Domenech M; González-Camacho F; Riksen NP; Aguilo N; Yuste J; Martín C; Netea MG
    PLoS Pathog; 2020 Apr; 16(4):e1008404. PubMed ID: 32240273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design.
    Covián C; Fernández-Fierro A; Retamal-Díaz A; Díaz FE; Vasquez AE; Lay MK; Riedel CA; González PA; Bueno SM; Kalergis AM
    Front Immunol; 2019; 10():2806. PubMed ID: 31849980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection.
    Dijkman K; Aguilo N; Boot C; Hofman SO; Sombroek CC; Vervenne RAW; Kocken CHM; Marinova D; Thole J; Rodríguez E; Vierboom MPM; Haanstra KG; Puentes E; Martin C; Verreck FAW
    Cell Rep Med; 2021 Jan; 2(1):100187. PubMed ID: 33521701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination.
    Vierboom MPM; Dijkman K; Sombroek CC; Hofman SO; Boot C; Vervenne RAW; Haanstra KG; van der Sande M; van Emst L; Domínguez-Andrés J; Moorlag SJCFM; Kocken CHM; Thole J; Rodríguez E; Puentes E; Martens JHA; van Crevel R; Netea MG; Aguilo N; Martin C; Verreck FAW
    Cell Rep Med; 2021 Jan; 2(1):100185. PubMed ID: 33521699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
    Clark S; Lanni F; Marinova D; Rayner E; Martin C; Williams A
    J Infect Dis; 2017 Sep; 216(5):525-533. PubMed ID: 28329234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trained innate immunity and resistance to Mycobacterium tuberculosis infection.
    Koeken VACM; Verrall AJ; Netea MG; Hill PC; van Crevel R
    Clin Microbiol Infect; 2019 Dec; 25(12):1468-1472. PubMed ID: 30807849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice.
    Aguilo N; Uranga S; Marinova D; Monzon M; Badiola J; Martin C
    Tuberculosis (Edinb); 2016 Jan; 96():71-4. PubMed ID: 26786657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro-American genetic background confers optimal vaccine potential.
    Pérez I; Uranga S; Sayes F; Frigui W; Samper S; Arbués A; Aguiló N; Brosch R; Martín C; Gonzalo-Asensio J
    EBioMedicine; 2020 May; 55():102761. PubMed ID: 32361249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose
    Peralta Alvarez MP; Jones H; Redondo Azema H; Davis C; White AD; Sarfas C; Dennis M; Li S; Wright D; Puentes E; Kimuda S; Belij-Rammerstorfer S; Aguilo N; Martin C; Sharpe S; McShane H; Tanner R
    Front Immunol; 2024; 15():1387454. PubMed ID: 38799468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunometabolic Pathways in BCG-Induced Trained Immunity.
    Arts RJW; Carvalho A; La Rocca C; Palma C; Rodrigues F; Silvestre R; Kleinnijenhuis J; Lachmandas E; Gonçalves LG; Belinha A; Cunha C; Oosting M; Joosten LAB; Matarese G; van Crevel R; Netea MG
    Cell Rep; 2016 Dec; 17(10):2562-2571. PubMed ID: 27926861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
    Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
    Front Immunol; 2018; 9():2371. PubMed ID: 30386336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG Vaccination Induces Long-Term Functional Reprogramming of Human Neutrophils.
    Moorlag SJCFM; Rodriguez-Rosales YA; Gillard J; Fanucchi S; Theunissen K; Novakovic B; de Bont CM; Negishi Y; Fok ET; Kalafati L; Verginis P; Mourits VP; Koeken VACM; de Bree LCJ; Pruijn GJM; Fenwick C; van Crevel R; Joosten LAB; Joosten I; Koenen H; Mhlanga MM; Diavatopoulos DA; Chavakis T; Netea MG
    Cell Rep; 2020 Nov; 33(7):108387. PubMed ID: 33207187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting innate immunity for tuberculosis vaccination.
    Khader SA; Divangahi M; Hanekom W; Hill PC; Maeurer M; Makar KW; Mayer-Barber KD; Mhlanga MM; Nemes E; Schlesinger LS; van Crevel R; Vankayalapati R(; Xavier RJ; Netea MG;
    J Clin Invest; 2019 Sep; 129(9):3482-3491. PubMed ID: 31478909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity.
    Kleinnijenhuis J; Quintin J; Preijers F; Benn CS; Joosten LA; Jacobs C; van Loenhout J; Xavier RJ; Aaby P; van der Meer JW; van Crevel R; Netea MG
    J Innate Immun; 2014; 6(2):152-8. PubMed ID: 24192057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in mice.
    Solans L; Uranga S; Aguilo N; Arnal C; Gomez AB; Monzon M; Badiola JJ; Gicquel B; Martin C
    Vaccine; 2014 Sep; 32(40):5192-7. PubMed ID: 25066740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis.
    Yin Y; Lian K; Zhao D; Tao C; Chen X; Tan W; Wang X; Xu Z; Hu M; Rao Y; Zhou X; Pan Z; Zhang X; Jiao X
    Front Cell Infect Microbiol; 2017; 7():407. PubMed ID: 29034213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice.
    Chuang YM; Pinn ML; Karakousis PC; Hung CF
    Front Cell Infect Microbiol; 2018; 8():31. PubMed ID: 29473022
    [No Abstract]   [Full Text] [Related]  

  • 20. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.